Weight-loss injectables like Zepbound are making as big of a splash as Viagra, if not bigger. What you need to know about the ‘miracle drugs’By Press Room31 January 2024 Obesity is among the world’s most common health conditions, but for years medicine had few effective approaches to offer short…
Novo Nordisk hits $500bn market value, climbing closer to the $1tn club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this yearBy Press Room31 January 2024 Novo Nordisk has shown few signs of slowing down since taking the pharmaceutical world by storm last year. Now, the…
North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030By Press Room27 January 2024 North Carolina is cutting off coverage of anti-obesity medications for state employees, citing soaring costs and a lack of agreement…